Press Releases, News & Announcements

08/06/19

Excelera® Specialty Pharmacy Network Welcomes HonorHealth

Second Arizona-based member to join the network, serving Scottsdale and Phoenix

06/25/19

Excelera Member Pharmacists Earn Exclusive “Certified Specialty Pharmacist” Accreditation

Specialty pharmacists within the Excelera Specialty Pharmacy Network continue to demonstrate strong commitment to high-caliber expertise in specialty pharmacy

04/16/19

Excelera Promotes Troy Polan to Chief Technology Officer

Tech exec elevated to CTO after success leading Excelera’s technology strategy to help drive partnerships and insights from sophisticated reporting and analytics platform

04/02/19

ExceleraRx Corp. Welcomes Senior Pharmacy Services Leader to Executive Suite

Don Amorosi brings 25 years of leadership experience developing solutions for pharmacy services

02/19/19

Excelera® Specialty Pharmacy Network Welcomes St. Luke’s Health System

Idaho-based health system becomes 22nd member of Excelera Network

02/12/19

ExceleraRx Corp. Expands Leadership Team with New Vice President, Manufacturer Relations

Rebecca Rand joins Excelera with over 20 years’ experience in a wide range of healthcare sectors, including specialty pharmacy, group purchasing, consulting and pharma

12/04/18

Nine Excelera Member Pharmacists Earn Exclusive “Certified Specialty Pharmacist” Accreditation

Over two-thirds of Excelera® members have at least one pharmacist on staff who has achieved the Specialty Pharmacy Certification Board’s CSP designation

09/24/18

Excelera® Specialty Pharmacy Network Announces Partnership with Smith & Nephew

ExceleraRx Corp. announced a partnership with Smith & Nephew for advanced wound care management products used in the treatment of acute and chronic wounds. These products will be made available through Excelera to health system specialty pharmacies.

07/17/18

Excelera® Specialty Pharmacy Network Announces Access to Breast Cancer Treatment NERLYNX™ for Health System-based Specialty Pharmacies

The U.S. Food and Drug Administration approved NERLYNX (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer in July 2017

07/10/18

Lorrie A. Carr Appointed as CEO for Excelera

Excelera has announced the appointment of Lorrie A. Carr as its new CEO. Ms. Carr succeeds Jim Fox who retired effective April 2. She assumed her responsibilities on July 9th.